Intratracheal perfluorocarbons diminish LPS-induced increase in systemic TNF-α

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 294, Issue 6, 2008, Pages

  Burkhardt, Wolfram ^a   Koehne, Petra ^b   Wissel, Heide ^b   Graf, Susanne ^b   Proquitté, Hans ^b   Wauer, Roland R ^b   Rüdiger, Mario ^a,b  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Anti inflammatory agents; Fluorocarbons; Lipopolysaccharide; Liquid ventilation; Tumor necrosis factor

Indexed keywords

FLUOROCARBON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; MESSENGER RNA; PF 5080; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR 1; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASSISTED VENTILATION; BLOOD LEVEL; BREATHING; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOHISTOCHEMISTRY; LIQUID VENTILATION; LUNG ALVEOLUS; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; ANIMAL; BIOSYNTHESIS; BLOOD; DRUG EFFECT; INTERMITTENT POSITIVE PRESSURE VENTILATION; LUNG; METABOLISM; TIDAL VOLUME; TRACHEA; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; FLUOROCARBONS; INTERLEUKIN-10; INTERMITTENT POSITIVE-PRESSURE VENTILATION; LIPOPOLYSACCHARIDES; LUNG; MALE; RATS; RATS, WISTAR; RNA, MESSENGER; TIDAL VOLUME; TRACHEA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 48949119360     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00125.2007     Document Type: Article

References (34)

1. Baba A, Kim Y, Zhang H, Liu M, Slutsky AS. Perfluorocarbon blocks tumor necosis factor-α-induced interleukin-8 release from alveolar epithelial cells in vitro. Crit Care Med 28: 1113-1118, 2000.
2. Bleyl JU, Ragaller M, Tschö U, Regner M, Kanzow M, Hübler M, Rasche S, Albrecht M. Vaporized perfluorocarbon improves oxygenation and pulmonary function in an ovine model of acute respiratory distress syndrome. Anesthesiology 91: 461-469, 1999.
3. Branca D, Chiarelli SM, Vincenti E, Tortorella C, Scutari G. Alteration of mitochondrial bioenergetics due to intravenous injection of a perfluorocarbon emulsion. Experientia 50: 660-663, 1994.
4. Colton DM, Hirschl RB, Johnson KJ, Till GO, Dean SB, Bartlett RH. Neutrophil infiltration is reduced during partial perfluorocarbon liquid ventilation in the setting of lung injury. Surg Forum 1055: 668-670, 1994.
5. Colton DM, Till GO, Johnson KJ, Dean SB, Bartlett RH, Hirschl RB. Neutrophil accumulation is reduced during partial liquid ventilation. Crit Care Med 1716-1724, 1998.
6. Costantino ML, Shaffer TH, Wauer RR, Rüdiger M. The 5th European Symposium on Perfluorocarbon (PFC) Application. ASAIO J 52: 483-484, 2006.
7. Fernandez R, Sarma V, Younkin E, Hirschl RB, Ward PA, Younger JG. Exposure to perflubron is associated with decreased Syk phosphorylation in human neutrophils. J Appl Physiol 91: 1941-1947, 2001.
8. Ghofrani HA, Rosseau S, Walmrath D, Kaddus W, Kramer A, Grimminger F, Lohmeyer J, Seeger W. Compartmentalized lung cytokine release in response to intravascular and alveolar endotoxin challenge. Am J Physiol Lung Cell Mol Physiol 270: L62-L68, 1996.
9. Guthmann F, Wissel H, Schachtrup C, Tölle A, Rüdiger M, Spener F, Rüstow B. Inhibition of TNF-alpha in vivo prevents hyperoxia-mediated activation of caspase 3 in type II cells. Respir Res 6: 10, 2005.
10. Hirschl RB, Croce MA, Gore D, Wiedemann HP, Davis KS, Zwischenberger J, Bartlett RH. Prospective, randomized, controlled pilot study of partial liquid ventilation in adult acute respiratory distress syndrome. Am J Respir Crit Care Med 165: 781-787, 2002.
11. Kacmarek RM, Wiedemann HP, Lavin PT, Wedel MK, Tütüncü AS, Slutsky AS. Partial liquid ventilation in adult patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 173: 882-889, 2006.
12. Kandler MA, von der Hardt K, Schoof E, Dötsch J, Rascher W. Persistent improvement of gas exchange and lung mechanics by aerosolized perfluorocarbon. Am J Respir Crit Care Med 164: 31-35, 2001.
13. Kawamae K, Pristine G, Chiumello D, Tremblay LN, Slutsky A. Partial liquid ventilation decreases serum tumor necrosis factor-α concentration in a rat aspiration lung injury model. Crit Care Med 28: 479-483, 2000.
14. Koch T, Ragaller M, Haufe M, Hofer A, Grosser M, Albrecht DM, Kotzsch M, Luther T. Perfluorohexane attenuates proinflammatory and procoagulatory response of activated monocytes and alveolar macrophages. Anesthesiology 94: 101-109, 2001.
15. Krunkosky TM, Fischer BM, Martin LD, Jones N, Akley NJ, Adler KB. Effects of TNF-α on expression of ICAM-1 in human airway epithelial cells in vitro. Am J Respir Cell Mol Biol 22: 685-692, 2000.
16. McRitchie DI, Isowa N, Edelson JD, Xavier AM, Cai L, Man HY, Wang YT, Keshavjee SH, Slutsky AS, Liu M. Production of tumor necrosis factor a by primary cultured rat alveolar epithelial cells. Cytokine 12: 644-654, 2000.
17. Murphy DB, Cregg N, Tremblay LN, Engelberts D, Laffey JG, Slutsky A, Romaschin A, Kavanagh BP. Adverse ventilatory strategy causes pulmonary-to-systemic translocation of endotoxin. Am J Respir Crit Care Med 126: 27-33, 2000.
18. Nakstad B, Wolfson MR, Shaffer TH, Kähler H, Lindemann R, Fugelseth D, Lyberg T. Perfluorochemical liquids modulate cell-mediated inflammatory responses. Crit Care Med 29: 1731-1737, 2001.
19. Obraztsov VV, Neslund G, Kornbrust E, Flaim S, Woods CM. In vitro cellular effects of perfluorochemicals correlate with their lipid solubility. Am J Physiol Lung Cell Mol Physiol 278: L1018-L1024, 2000.
20. Proquitté H, Rüdiger M, Wauer RR, Schmalisch G. Measurements of evaporated perfluorocarbon during partial liquid ventilation by a zeolite absorber. Artif Cells Blood Substit Immobil Biotechnol 32: 375-386, 2004.
21. Pugin J, Dunn I, Jolliet P, Tassaux D, Magnenat JL, Nicod LP, Chevrolet JC. Activation of human macrophages by mechanical ventilation in vitro. Am J Physiol Lung Cell Mol Physiol 275: L1040-L1050, 1998.
22. Rotta AT, Steinhorn DM. Partial liquid ventilation reduces pulmonary neutrophil accumulation in an experimental model of systemic endotoximia and acute lung injury. Crit Care Med 26: 1707-1715, 1998.
23. Rüdiger M, Köpke U, Prösch S, Rauprich P, Wauer RR, Herting E. Effects of perfluorocarbons and perfluorocarbons/surfactant- emulsions on growth and viability of group B streptococci and Escherichia coli. Crit Care Med 29: 1786-1791, 2001.
24. Rüdiger M, Some M, Jarstrand C, Calkovska A, Linderholm B, Robertson B, Herting E. Influence of partial liquid ventilation on bacterial growth and alveolar expansion in newborn rabbits with group B-streptococcal pneumonia. Pediatr Res 54: 808-813, 2003.
25. Sabat R, Kolleck I, Witt W, Volk HD, Sinha P, Rüstow B. Immunological dysregulation of lung cells in response to vitamin E deficiency. Free Radic Biol Med 30: 1145-1153, 2001.
26. Steinhorn DM, Rotta AT. Liquid ventilation. Acta Anaesthesiol Scand Suppl 11: 140-143, 1998.
27. Thomassen MJ, Buhrow LT, Wiedemann HP. Perflubron decreases inflammatory cytokine production by human alveolar macrophages. Crit Care Med 25: 2045-2047, 1997.
28. Varani J, Hirschl RB, Dame M, Johnson K. Perfluorocarbon protects lung epithelial cells from neutrophil-mediated injury in an in vitro model of liquid ventilation therapy. Shock 6: 339-344, 1996.
29. von der Hardt K, Schoof E, Kandler MA, Dötsch J, Rascher W. Aerosolized perfluorocarbon suppresses early pulmonary inflammatory response in a surfactant-depleted piglet model. Pediatr Res 51: 177-182, 2002.
30. Williams EA, Welty SE, Geske RS, Hubble CL, Craig DM, Quick G, Meliones JN, Cheifetz IM. Liquid lung ventilation reduces neutrophil sequestration in a neonatal swine model of cardiopulmonary bypass. Crit Care Med 29: 789-795, 2001.
31. Wissel H, Burkhardt W, Rupp J, Wauer RR, Rüdiger M. Perfluorocarbons decrease Chlamydophila pneumoniae-mediated inflammatory responses of rat type II pneumocytes in vitro. Pediatr Res 60: 264-269, 2006.
32. Wissel H, Schulz C, Koehne P, Richter E, Maass M, Rüdiger M. Chlamydophila pneumoniae induces expression of Toll-like receptor 4 and release of TNF-α and MIP-2 via NF-κB pathway in rat type II pneumocytes. Respir Res 6: 51, 2005.
33. Wolfson MR, Greenspan JS, Deoras KS, Rubenstein SD, Shaffer TH. Comparison of gas and liquid ventilation: clinical, physiological, and histological correlates. J Appl Physiol 72: 1024-1031, 1992.
34. Woods CM, Neslund G, Kornbrust E, Flaim SF. Perflubron attenuates neutrophil adhesion to activated endothelial cells in vitro. Am J Physiol Lung Cell Mol Physiol 278: L1008-L1017, 2000.